Commission Regulation (EU) 2025/1101 of 3 June 2025 amending Regulation (EU) 2018/782 concerning the assessment by the European Medicines Agency of maximum residue limits for chemical-unlike biological substances

In section I.7. of Annex I to Regulation (EU) 2018/782, the second paragraph is replaced by the following: ‘The information provided above shall be evaluated in accordance with the guidance published by the European Medicines Agency (“Agency”) in order to determine whether a “no MRL required” classification according to the classification provided for under Article 14(2), point (c), of Regulation (EC) No 470/2009 is appropriate.’.

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.